Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Depression
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Depression
    Prediction of Long-Term Remission in Major Depressive Disorder Allows for Early Treatment Adjustments: Presented at ECNP - (DGDispatch)
    TopAbstracts in Depression 09/03/2008 - (DGNews)
    Brief, 3-Question Scale Effective in Uncovering Postpartum Depression - (DGNews)
    The ECNP Consensus Statement on Bipolar Depression - (DGNews)
    Montelukast Does Not Cause Depression or Suicide, American Lung Association Study Concludes - (DGNews)

    News archive

     Recent webcasts/CME - Depression
    Recognition and Management of Depression
    Understanding the Vital Link: Depression and Chronic Disease

    Webcasts/CME archive

     Recent cases - Depression
      A Postmenopausal Woman Presenting with Ekbom Syndrome Associated with Recurrent Depressive Disorder: A Case Report
      Affective Psychosis, Hashimoto's Thyroiditis, and Brain Perfusion Abnormalities: Case Report
      Dissecting the Determinants of Depressive Disorders Outcome: An in Depth Analysis of Two Clinical Cases
      Incomplete Oedipism and Chronic Suicidality in Psychotic Depression with Paranoid Delusions Related to Eyes
      Excessive Weight Gain after Remission of Depression in a Schizophrenic Patient Treated with Risperidone: Case Report

      Cases archive
        




      my personal edition > depression > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Patients with Non-melancholic Depression Might Respond Better to Sertraline than Imipramine

      A DGReview of :"Sertraline is more effective than imipramine in the treatment of non-melancholic depression: Results from a multicentre, randomized study"
      Progress in Neuro-Psychopharmacology & Biological Psychiatry

      04/17/2003
      By Veronica Rose


      Sertraline appears to be more effective than imipramine for treating the symptoms of acute depression and anxiety in patients with non-melancholic depression, according to Spanish researchers.

      They undertook an open-label, parallel group study at Hospital Puerta de Hierro in Madrid to compare efficacy, tolerability and effect on the health-related quality of life between sertraline and imipramine for the management of non-melancholic depression.

      A total of 116 patients were randomised to receive sertraline 50-200 mg/day and 123 were given imipramine 75-225 mg/day for 8 weeks.

      The intent-to-treat, last-observation-carried-forward analysis showed that sertraline produced significantly greater improvements in depressive symptoms and anxiety symptoms. Scores on the 21-item Hamilton Depression Rating Scale were reduced from 24.9 and 24.4 to 10.3 and 13.1 at end point, respectively (P<.005). Scores on the Hamilton Anxiety Rating Scale were reduced from 21.8 and 21.9 to 9.5 and 13.9, respectively (P<.01).

      Response and remission rates also improved significantly at end point with sertraline by comparison with imipramine (69.0% versus 53.7% and 51.3% versus 38.0%; P=.016 and P=.041, respectively) from the fourth week onwards.

      Using the Clinical Global Impressions Scale of Improvement, more patients who received sertraline were considered to be very much improved or much improved compared to those treated with imipramine (76.1% vs. 62.8 %, P=.028).

      By Week 8, patients in both groups displayed clear quality of life improvements, but the difference between groups was not statistical significant. However, sertraline was significantly better tolerated and fewer patients discontinued therapy due to adverse events compared to imipramine (10.3% vs. 24.4%, P=.004).
      Prog Neuropsycholpharmacol Bio Psychiatry 2003;27:3:493-500. "Sertraline is more effective than imipramine in the treatment of non-melancholic depression: Results from a multicentre, randomized study"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send